loadpatents
name:-0.071823835372925
name:-0.029109954833984
name:-0.025591850280762
Blumberg; Richard S. Patent Filings

Blumberg; Richard S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Blumberg; Richard S..The latest application filed is for "use of anti-fcrn antibodies in the treatment of pemphighus and pemphigoid diseases".

Company Profile
22.24.55
  • Blumberg; Richard S. - Weston MA
  • Blumberg; Richard S. - Waltham MA
  • BLUMBERG; Richard S. - Boston MA
  • Blumberg; Richard S - Waltham MA
  • Blumberg; Richard S. - Chestnut Hill MA US
  • Blumberg; Richard S. - Chestnut MA
  • Blumberg, Richard S. - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use Of Anti-fcrn Antibodies In The Treatment Of Pemphighus And Pemphigoid Diseases
App 20220298241 - Blumberg; Laurence J. ;   et al.
2022-09-22
Humanized and Affinity-Matured Anti-CEACAM1 Antibodies
App 20220025040 - Blumberg; Richard S. ;   et al.
2022-01-27
Compositions And Methods For Modulating An Immune Response
App 20210347887 - Blumberg; Richard S. ;   et al.
2021-11-11
Therapeutic Fcrn-based Bispecific Monoclonal Antibodies
App 20210139582 - BLUMBERG; Richard S. ;   et al.
2021-05-13
Therapeutic And Immunomodulatory Bacteriophage Formulations And Methods For Making And Using Them
App 20210062160 - ROHWER; Forest ;   et al.
2021-03-04
Oxazole Containing Compounds As Activators Of Ido1 And Ahr
App 20210009535 - BLUMBERG; Richard S. ;   et al.
2021-01-14
Humanized affinity matured anti-FcRn antibodies
Grant 10,822,417 - Blumberg , et al. November 3, 2
2020-11-03
Compositions And Methods For Treating Subjects With Immune-mediated Diseases
App 20200241001 - BLUMBERG; Richard S. ;   et al.
2020-07-30
HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
App 20200207854 - Blumberg; Laurence J. ;   et al.
2020-07-02
HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
App 20200181262 - Blumberg; Laurence J. ;   et al.
2020-06-11
Humanized affinity matured anti-FcRn antibodies
Grant 10,626,175 - Blumberg , et al.
2020-04-21
Modulation Of The Immune Response
App 20200095284 - BLUMBERG; RICHARD S. ;   et al.
2020-03-26
FC receptor (FcRn) binding peptides and uses thereof
Grant 10,588,935 - Blumberg , et al.
2020-03-17
Compositions And Methods For Modulating An Immune Response
App 20200040076 - Blumberg; Richard S. ;   et al.
2020-02-06
Methods To Manipulate Alpha-fetoprotein (afp)
App 20200031928 - BLUMBERG; Richard S. ;   et al.
2020-01-30
Compositions And Methods For Modulating An Immune Response
App 20200024343 - Blumberg; Richard S. ;   et al.
2020-01-23
FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
App 20200023034 - Blumberg; Richard S. ;   et al.
2020-01-23
Methods To Manipulate Alpha-fetoprotein (afp)
App 20200010543 - BLUMBERG; Richard S. ;   et al.
2020-01-09
Modulation of the immune response
Grant 10,513,540 - Blumberg , et al. Dec
2019-12-24
Targeting Oxazole Structures For Therapy Against Inflammatory Diseases
App 20190225683 - BLUMBERG; Richard S. ;   et al.
2019-07-25
Enhancement Of The Immune Response
App 20190201524 - BLUMBERG; Richard S. ;   et al.
2019-07-04
Blockade Of Alphafetoprotein (afp) Interactions With Beta2-microglobulin Associated Molecules
App 20190201496 - BLUMBERG; Richard S. ;   et al.
2019-07-04
Glycosphingolipids and methods of use thereof
Grant 10,329,315 - Kasper , et al.
2019-06-25
FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
App 20190183964 - BLUMBERG; Richard S. ;   et al.
2019-06-20
Compositions And Methods For Modulating An Immune Response
App 20190169290 - Blumberg; Richard S. ;   et al.
2019-06-06
HUMANIZED AFFINITY MATURED ANTI-FcRn ANTIBODIES
App 20190135915 - Blumberg; Laurence J. ;   et al.
2019-05-09
Interactions Between Ceacam And Tim Family Members
App 20180298095 - BLUMBERG; Richard S. ;   et al.
2018-10-18
HUMAZNIZED AFFINITY MATURED ANIT-FcRn ANTIBODIES
App 20180291101 - Blumberg; Laurence J. ;   et al.
2018-10-11
FC receptor (FcRn) binding peptides and uses thereof
Grant 10,046,023 - Blumberg , et al. August 14, 2
2018-08-14
Compositions and methods for modulating an immune response
Grant 10,035,858 - Blumberg , et al. July 31, 2
2018-07-31
Interactions Between Ceacam And Tim Family Members
App 20180153986 - BLUMBERG; Richard S. ;   et al.
2018-06-07
Receptor-targeted Nanoparticles For Enhanced Transcytosis Mediated Drug Delivery
App 20180021455 - Pridgen; Eric M. ;   et al.
2018-01-25
Anti-ceacam1 Recombinant Antibodies For Cancer Therapy
App 20170327578 - BLUMBERG; Richard S. ;   et al.
2017-11-16
FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
App 20170209529 - BLUMBERG; Richard S. ;   et al.
2017-07-27
Assays and methods to sequence microbes directly from immune complexes
Grant 9,689,044 - Blumberg , et al. June 27, 2
2017-06-27
Methods To Manipulate Alpha-fetoprotein (afp)
App 20170044257 - BLUMBERG; Richard S. ;   et al.
2017-02-16
Compositions And Methods For Treating Subjects With Immune-mediated Diseases
App 20170045528 - BLUMBERG; Richard S. ;   et al.
2017-02-16
Anti-CEACAM1 recombinant antibodies for cancer therapy
Grant 9,556,271 - Blumberg , et al. January 31, 2
2017-01-31
Receptor-targeted Nanoparticles For Enhanced Transcytosis Mediated Drug Delivery
App 20170000899 - Pridgen; Eric M. ;   et al.
2017-01-05
Compositions And Methods For Modulating An Immune Response
App 20170002073 - Blumberg; Richard S. ;   et al.
2017-01-05
FC receptor (FcRn) binding peptides and uses thereof
Grant 9,527,890 - Blumberg , et al. December 27, 2
2016-12-27
FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
App 20160122394 - BLUMBERG; Richard S. ;   et al.
2016-05-05
Enhancement Of The Immune Response
App 20150273056 - Blumberg; Richard S ;   et al.
2015-10-01
Glycosphingolipids And Methods Of Use Thereof
App 20150252068 - Kasper; Dennis L. ;   et al.
2015-09-10
Modulation Of The Immune Response
App 20150225457 - Blumberg; Richard S. ;   et al.
2015-08-13
Anti-ceacam1 Recombinant Antibodies For Cancer Therapy
App 20140328841 - Blumberg; Richard S. ;   et al.
2014-11-06
Methods of treating and preventing colitis involving IL-13 and NK-T cells
Grant 8,821,866 - Strober , et al. September 2, 2
2014-09-02
Assays And Methods To Sequence Microbes Directly From Immune Complexes
App 20130330715 - Blumberg; Richard S. ;   et al.
2013-12-12
Methods Of Treating And Preventing Colitis Involving Il-13 And Nk-t Cells
App 20120276113 - Strober; Warren ;   et al.
2012-11-01
Disrupting FCRN-albumin interactions
Grant 8,232,067 - Blumberg , et al. July 31, 2
2012-07-31
T Cell Inhibitory Receptor Compositions And Uses Thereof
App 20120141470 - Blumberg; Richard S.
2012-06-07
Disrupting FCRN-Albumin Interactions
App 20120107845 - Blumberg; Richard S. ;   et al.
2012-05-03
T cell inhibitory receptor compositions and uses thereof
Grant 8,110,189 - Blumberg February 7, 2
2012-02-07
Methods Of Treating And Preventing Colitis Involving Il-13 And Nk-t Cells
App 20100143339 - Strober; Warren ;   et al.
2010-06-10
Methods of treating and preventing colitis involving IL-13 and NK-T cells
Grant 7,666,411 - Strober , et al. February 23, 2
2010-02-23
Receptor specific transepithelial transport of therapeutics
Grant 7,547,436 - Blumberg , et al. June 16, 2
2009-06-16
T cell inhibitory receptor compositions and uses thereof
App 20080102071 - Blumberg; Richard S.
2008-05-01
Receptor specific transepithelial transport of therapeutics
App 20070020192 - Blumberg; Richard S. ;   et al.
2007-01-25
Identification of compounds that bind biliary glycoprotein and affect cytotoxic T lymphocyte activity
Grant 7,132,255 - Blumberg November 7, 2
2006-11-07
Central airway administration for systemic delivery of therapeutics
App 20060140907 - Blumberg; Richard S. ;   et al.
2006-06-29
Receptor specific transepithelial transport in therapeutics
Grant 7,067,129 - Blumberg , et al. June 27, 2
2006-06-27
Receptor specific transepithelial transport of therapeutics
Grant 7,060,274 - Blumberg , et al. June 13, 2
2006-06-13
Methods of treating and preventing colitis involving il-13 and nk-t cells
App 20060024306 - Strober; Warren ;   et al.
2006-02-02
Methods of inhibiting inflammation
App 20050234073 - Blumberg, Richard S.
2005-10-20
T cell inhibitory receptor compositions and uses thereof
App 20050169922 - Blumberg, Richard S.
2005-08-04
Methods of inhibiting inflammation
App 20050090426 - Blumberg, Richard S.
2005-04-28
T cell inhibitory receptor compositions and uses thereof
Grant 6,852,320 - Blumberg February 8, 2
2005-02-08
Central airway administration for systemic delivery of therapeutics
App 20040063912 - Blumberg, Richard S. ;   et al.
2004-04-01
Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof
App 20040047858 - Blumberg, Richard S. ;   et al.
2004-03-11
Central airway administration for systemic delivery of therapeutics
App 20030235536 - Blumberg, Richard S. ;   et al.
2003-12-25
Receptor specific transepithelial transport of therapeutics
App 20030012789 - Blumberg, Richard S. ;   et al.
2003-01-16
Receptor specific transepithelial transport of therapeutics
App 20020192222 - Blumberg, Richard S. ;   et al.
2002-12-19
Receptor specific transepithelial transport of therapeutics
Grant 6,485,726 - Blumberg , et al. November 26, 2
2002-11-26
T cell inhibitory receptor compositions and uses thereof
App 20020028203 - Blumberg, Richard S.
2002-03-07
Receptor specific transepithelial transport of immunogens
Grant 6,086,875 - Blumberg , et al. July 11, 2
2000-07-11
Receptor specific transepithelial transport of therapeutics
Grant 6,030,613 - Blumberg , et al. February 29, 2
2000-02-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed